section name header
Index
5-fluorouracil, dose and schedule of
5-fluorouracil and mitomycin c vs induction cisplatin and 5-fluorouracil
causative agent
chemotherapy
continuous radiation therapy vs planned 2-week treatment
ECOG 1289/RTOG 87-04 study
EORTC 22861 study
histologic types
IMRT planning
incidence rate
locoregional failure rate
major changes in the 8th edition TNM staging
mitomycin-c, dose and schedule of
mortality rate
nonkeratinizing squamous cell carcinoma
radiation therapy combined with 5-fluorouracil and mitomycin-C
risk for regional spread
RTOG 98-11 trial
squamous cell carcinoma of
superior aspect
time to assess for complete clinical response after chemoradiation
toxicities of 5-fluorouracil
treatment-related toxicities
tumor location
UKCCCR Anal Cancer Trial Working Party trial